With traditional taboos receding, and the biotechnology and pharmaceutical sectors in flux, some researchers are moving from industry back to academia. Quirin Schiermeier looks at the trade-offs.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Related external links
University of Dundee drug discovery unit
Rights and permissions
About this article
Cite this article
Schiermeier, Q. The way back. Nature 466, 402–403 (2010). https://doi.org/10.1038/nj7304-402a
Published:
Issue date:
DOI: https://doi.org/10.1038/nj7304-402a
This article is cited by
-
Education: Outside the box
Nature (2012)
